Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review

Keyphrases

• Moderate to Severe 100%
• Systematic Narrative Review 100%
• Severe Alopecia Areata 100%
• Janus Kinase Inhibitors 80%
• Baricitinib 80%
• Randomized Controlled Trial 60%
• Placebo 60%
• Alopecia Areata 60%
• Drug Class 40%
• Clinical Outcomes 20%
• Severe Disease 20%
• Clinical Practice 20%
• Adverse Effects 20%
• Patient Management 20%
• Adult Patients 20%
• Clinical Trials 20%
• Tolerability 20%
• Systematic Literature Review 20%
• Narrative Review 20%
• Safety Profile 20%
• Network Meta-analysis 20%
• Data Extraction 20%
• Janus Kinase 1 (JAK1) 20%
• Current Management 20%
• Clinical Endpoints 20%
• Non-randomized Trial 20%
• Treatment Use 20%
• Indirect Comparison 20%
• Hair Loss 20%
• JAK2 Inhibitor 20%
• Hair Regrowth 20%
• Scalp Hair 20%
• Kinase Inhibitor Therapy 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Alopecia Areata 100%
• Janus Kinase Inhibitor 50%
• Baricitinib 50%
• Placebo 37%
• Randomized Controlled Trial 37%
• Adverse Event 12%
• Observational Study 12%
• Clinical Trial 12%
• Tolerability 12%
• Minoxidil 12%
• Hair Loss 12%
• Janus Kinase 2 Inhibitor 12%

Immunology and Microbiology

• Alopecia Areata 100%
• Arm 12%
• Data Extraction 12%
• Scalp Hair 12%